{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.1052","meta":{"versionId":"5","lastUpdated":"2022-03-01T16:14:22.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2022-03-01"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1052","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.1052"}],"version":"20210909","name":"CardiovascularAlphaAgonistsCentral","title":"Cardiovascular, alpha agonists, central","status":"active","experimental":false,"date":"2021-09-09T01:01:05-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts for guanfacine and methyldopa medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients.)","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1252"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1257"]}]},"expansion":{"identifier":"urn:uuid:04eb1b21-0257-4913-b429-ed5ea9bc0a97","timestamp":"2023-12-11T02:05:03-05:00","total":10,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197745","display":"guanfacine 1 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197746","display":"guanfacine 2 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197956","display":"methyldopa 250 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197958","display":"methyldopa 500 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197960","display":"hydrochlorothiazide 25 MG / methyldopa 250 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197963","display":"hydrochlorothiazide 15 MG / methyldopa 250 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"862006","display":"24 HR guanfacine 1 MG Extended Release Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"862013","display":"24 HR guanfacine 2 MG Extended Release Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"862019","display":"24 HR guanfacine 3 MG Extended Release Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"862025","display":"24 HR guanfacine 4 MG Extended Release Oral Tablet"}]}}